Sunshine Biopharma (SBFM) Change in Taxes (2022 - 2026)
Sunshine Biopharma (SBFM) posted Change in Taxes of $175.0 for Q1 2026, up 100.11% on a QoQ basis from -$152874.0 in Q4 2025, and up 100.44% year-over-year from $87.31 in Q1 2025.
Sunshine Biopharma (SBFM) Change in Taxes (2022 - 2026) Analysis & Trends
Sunshine Biopharma's Change in Taxes history runs 5 years deep, the most recent figure standing at $175.0 for Q1 2026.
- Quarterly Change in Taxes rose 100.44% year-over-year to $175.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $40336.0 (up 104.99% YoY) and the FY2024 annual result came in at -$812080.0, down 1008.69% from the prior year.
- Change in Taxes was $175.0 for Q1 2026 at Sunshine Biopharma, up from -$152874.0 in the prior quarter.
- Across five years, Change in Taxes topped out at $1.0 million in Q4 2023 and bottomed at -$1.2 million in Q2 2024.
- A 5-year average of -$46176.6 and a median of -$19993.0 in 2025 frame the typical range for Change in Taxes.
- Annual changes were most pronounced in 2023 — Change in Taxes surged 323.55% — and 2024, when it slumped 530.84%.
- Sunshine Biopharma's Change in Taxes stood at $238679.0 in 2022, then jumped by 323.55% to $1.0 million in 2023, then slumped by 108.35% to -$84452.0 in 2024, then tumbled by 81.02% to -$152874.0 in 2025, then jumped by 100.11% to $175.0 in 2026.
- Business Quant data shows SBFM's Change in Taxes at $175.0 in Q1 2026, -$152874.0 in Q4 2025, and $162992.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 73.00 Mn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -411.14 Mn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | -463.40 Mn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 119.80 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Sunshine Biopharma | 750,608.81 | -6.16 Mn | 2.18 Mn | 175.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 175.00 |
| Mar 31, 2026 | 175.00 |
| Dec 31, 2025 | -152,874.00 |
| Dec 31, 2025 | -152,874.00 |
| Sep 30, 2025 | 162,992.00 |
| Sep 30, 2025 | 162,992.00 |
| Jun 30, 2025 | 30,043.00 |
| Jun 30, 2025 | 30,043.00 |
| Mar 31, 2025 | -40,161.00 |
| Mar 31, 2025 | -40,161.00 |
| Dec 31, 2024 | -84,452.00 |
| Dec 31, 2024 | -84,452.00 |
| Sep 30, 2024 | 520,043.00 |
| Sep 30, 2024 | 520,043.00 |
| Jun 30, 2024 | -1.20 Mn |
| Jun 30, 2024 | -1.20 Mn |
| Mar 31, 2024 | -43,824.00 |
| Mar 31, 2024 | -43,824.00 |
| Dec 31, 2023 | 1.01 Mn |
| Dec 31, 2023 | 1.01 Mn |